These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 17128639)

  • 1. Noninvasive tests for liver fibrosis.
    Luxon BA
    Postgrad Med; 2006; 119(3):8-13. PubMed ID: 17128639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-invasive diagnosis of advanced fibrosis and cirrhosis.
    Sharma S; Khalili K; Nguyen GC
    World J Gastroenterol; 2014 Dec; 20(45):16820-30. PubMed ID: 25492996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-alcoholic fatty liver disease - histological scoring systems: a large cohort single-center, evaluation study.
    Rastogi A; Shasthry SM; Agarwal A; Bihari C; Jain P; Jindal A; Sarin S
    APMIS; 2017 Nov; 125(11):962-973. PubMed ID: 29076589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current complications and challenges in nonalcoholic steatohepatitis screening and diagnosis.
    Golabi P; Sayiner M; Fazel Y; Koenig A; Henry L; Younossi ZM
    Expert Rev Gastroenterol Hepatol; 2016; 10(1):63-71. PubMed ID: 26469309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noninvasive tools to assess hepatic fibrosis: ready for prime time?
    Schmeltzer PA; Talwalkar JA
    Gastroenterol Clin North Am; 2011 Sep; 40(3):507-21. PubMed ID: 21893271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum laboratory markers for noninvasive diagnosis and monitoring of liver fibrogenesis in patients with chronic liver diseases.
    Vozar I
    Bratisl Lek Listy; 2005; 106(3):123-6. PubMed ID: 16026147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The evaluation of hepatic fibrosis scores in children with nonalcoholic fatty liver disease.
    Mansoor S; Yerian L; Kohli R; Xanthakos S; Angulo P; Ling S; Lopez R; Christine CK; Feldstein AE; Alkhouri N
    Dig Dis Sci; 2015 May; 60(5):1440-7. PubMed ID: 25540086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease.
    Ratziu V; Massard J; Charlotte F; Messous D; Imbert-Bismut F; Bonyhay L; Tahiri M; Munteanu M; Thabut D; Cadranel JF; Le Bail B; de Ledinghen V; Poynard T; ;
    BMC Gastroenterol; 2006 Feb; 6():6. PubMed ID: 16503961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The predictive value of noninvasive serum markers of liver fibrosis in patients with chronic hepatitis C.
    Gökcan H; Kuzu UB; Öztaş E; Saygılı F; Öztuna D; Suna N; Tenlik İ; Akdoğan M; Kaçar S; Kılıç ZM; Kayaçetin E
    Turk J Gastroenterol; 2016 Mar; 27(2):156-64. PubMed ID: 26853790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and Evaluation of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis, Including Noninvasive Biomarkers and Transient Elastography.
    Tsai E; Lee TP
    Clin Liver Dis; 2018 Feb; 22(1):73-92. PubMed ID: 29128062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninvasive assessment of fibrosis and steatosis in NASH and ASH.
    Angulo P
    Gastroenterol Clin Biol; 2009; 33(10-11):940-8. PubMed ID: 19800187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noninvasive assessment of liver fibrosis: serum markers, imaging, and other modalities.
    Guha IN; Rosenberg WM
    Clin Liver Dis; 2008 Nov; 12(4):883-900, x. PubMed ID: 18984472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver fibrosis markers of nonalcoholic steatohepatitis.
    Enomoto H; Bando Y; Nakamura H; Nishiguchi S; Koga M
    World J Gastroenterol; 2015 Jun; 21(24):7427-35. PubMed ID: 26139988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninvasive biochemical markers of liver fibrosis.
    Grigorescu M
    J Gastrointestin Liver Dis; 2006 Jun; 15(2):149-59. PubMed ID: 16802010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simple non-invasive markers as a predictor of fibrosis and viral response in chronic hepatitis C patients.
    Arabul M; Aslan F; Alper E; Akpinar Z; Çelık M; Kandemır A; Vatansever S; Ünsal B
    Turk J Gastroenterol; 2012; 23(5):538-45. PubMed ID: 23161299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnosis of hepatic fibrosis and cirrhosis].
    Arends JE; de Knegt RJ; van Erpecum KJ; Hoepelman IM
    Ned Tijdschr Geneeskd; 2007 Jul; 151(27):1502-6. PubMed ID: 17763808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating Diagnostic Accuracy of Noninvasive Tests in Assessment of Significant Liver Fibrosis in Chronic Hepatitis C Egyptian Patients.
    Omran D; Zayed RA; Nabeel MM; Mobarak L; Zakaria Z; Farid A; Hassany M; Saif S; Mostafa M; Saad OK; Yosry A
    Viral Immunol; 2018 May; 31(4):315-320. PubMed ID: 29630460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying Nonalcoholic Fatty Liver Disease Advanced Fibrosis in the Veterans Health Administration.
    Patel YA; Gifford EJ; Glass LM; Turner MJ; Han B; Moylan CA; Choi S; Suzuki A; Provenzale D; Hunt CM
    Dig Dis Sci; 2018 Sep; 63(9):2259-2266. PubMed ID: 29779083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive value of biomarkers of hepatic fibrosis in adult Fontan patients.
    Wu FM; Earing MG; Aboulhosn JA; Johncilla ME; Singh MN; Odze RD; Ukomadu C; Gauvreau K; Landzberg MJ; Valente AM;
    J Heart Lung Transplant; 2017 Feb; 36(2):211-219. PubMed ID: 27592026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of Serum Marker Models to Increase Diagnostic Accuracy of Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: The New LINKI Algorithm Compared with Established Algorithms.
    Lykiardopoulos B; Hagström H; Fredrikson M; Ignatova S; Stål P; Hultcrantz R; Ekstedt M; Kechagias S
    PLoS One; 2016; 11(12):e0167776. PubMed ID: 27936091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.